Affordable Access

Access to the full text

Clinical and echocardiographic trends in percutaneous balloon mitral valvuloplasty

Authors
  • Koren, Ofir1, 2
  • Israeli, Asaf2
  • Rozner, Ehud1
  • Darawshy, Nassem3
  • Turgeman, Yoav1, 2
  • 1 Heart Institute, Emek Medical Center, 21 Yitzhak Rabin Boulevard, Afula, 18101, Israel , Afula (Israel)
  • 2 Technion Israel Institute of Technology, Haifa, Israel , Haifa (Israel)
  • 3 Emek Medical Center, Afula, Israel , Afula (Israel)
Type
Published Article
Journal
Journal of Cardiothoracic Surgery
Publisher
Springer (Biomed Central Ltd.)
Publication Date
Apr 01, 2021
Volume
16
Issue
1
Identifiers
DOI: 10.1186/s13019-021-01442-w
Source
Springer Nature
Keywords
License
Green

Abstract

BackgroundThe prevalence of Rheumatic Mitral Stenosis (MS) has significantly changed over the last decades. We intend to examine patient demographics, Echocardiographic characteristics, procedural success rates, and complications throughout 30-years.MethodsWe conducted a single-center descriptive observational study. The study population consists of patients undergone percutaneous balloon mitral valvuloplasty (PBMV) at Emek Medical Center in Israel from January 1990 to May 2019.ResultsFour hundred seventeen patients underwent PBMV during the study period and were eligible for the study. Age did not change significantly over time (p = 0.09). The prevalence of Male and patients who were smoking and had multiple comorbidities such as hypertension, dyslipidemia, ischemic heart disease, and chronic kidney disease became increases over time (p = 0.02, p = 0.02, p = 0.001, p = 0.01, p = 0.02, and p = 0.001, respectively). Wilkins score and all its components increased over time, and the total score was higher in females (p = 0.01). Seventy-nine (18.9%) patients had complications. The rate of complications did not change over decades. Patients with Wilkins score > 8, post-procedural MR of ≥2, and post-procedural MVA < 1.5 had the highest risk for the need of Mitral valve replacement (MVR) surgery in 2 years following PBMV (3.64, 4.03, 2.44, respectively, CI 95%, p < .0001 for all). The median time in these patients was 630 days compared to 4–5 years in the entire population. Patients with Post-procedural MR of ≥2 and post-procedural MVA < 1.5 had ten times risk for developing heart failure (HR 9.07 and 10.06, respectively, CI 95%, P < .0001).ConclusionOur research reveals trends over time in patients’ characteristics and echocardiographic features. Our study population consists of more male patients with multiple comorbidities and more complex and calcified valvular structures in the last decade. Wilkins score > 8, post-procedural MR of ≥2, and post-procedural MVA < 1.5 cm2 were in-depended predictors for the time for surgery and heart failure hospitalization.

Report this publication

Statistics

Seen <100 times